Susceptibilities of 98 clinical isolates of Pseudomonas aeruginosa, including 33 strains with known mechanisms of amikacin resistance, were tested by the agar dilution method against 10 13-lactam drugs. Ceftazidime, imipenem, and cefsulodin had the greatest activity, regardless of the aminoglycoside susceptibilities. The strains which were highly resistant to amikacin appeared to be less susceptible to some ,B-lactam drugs, especially if their resistance was related to amikacin-inactivating enzymes; statistical significance, however, was observed for aztreonam only.
Serious infections caused by Pseudomonas aeruginosa continue to be difficult to treat and are associated with a high mortality rate (2, 3) . The use of aminoglycosides as single drugs or agents used in combination with P-lactam antimicrobial agents can be associated with both nephrotoxicity and ototoxicity (1, 5) . The use of extended-spectrum ,Blactams as well as the new monobactam class of antimicrobial agents has generated increasing interest in the therapy of P. aeruginosa infections (4, 6, 8-11, 13, 14, 16 Md.). Inocula were prepared from a 4-to 6-h broth culture of the organisms. The turbidity was initially adjusted to 1 CFU/ml, and 0.001 ml of the final inoculum was applied to * Corresponding author.
the duplicate plates with a Steers replicator (15). Antibiotic solutions were prepared on the day of use.
Observed differences in the distributions of antibiotic MICs for P. aeruginosa strains were analyzed statistically with the Kruskal-Wallis statistic, which was corrected for ties (7) . Tests of null hypotheses were performed at a level of significance of 0.05. Table 1 shows the susceptibilities of all 98 P. aeruginosa strains to 13 antibiotics divided into three groups, depending on their susceptibilities to aminoglycosides (susceptible, intermediate, or resistant). There were no statistically significant increases in the ,-lactam MICs with increasing aminoglycoside resistance. These observations are in contrast to those in a report by Preheim et al. (12) , in which it is suggested that induced resistance to 0-lactams may be associated with increasing resistance to aminoglycosides. The isolates in our study, however, may have been uninduced. Table 2 shows the ,-lactam drug susceptibilities of 33 P. aeruginosa strains with known mechanisms of resistance to amikacin (13 strains with decreased uptake and 20 strains with enzymatic inhibition). Although the MICs of the 1- lactams for 50 and 90%o of strains (MIC50 and MIC90, respectively) appear higher for the strains showing enzyme inactivation than for those with decreased di-ug uptake, statistical significance (P < 0.05) was found only for aztreonam.
Our overall P. aeruginosa susceptibility data for ,B-lactam antibiotics compare closely with those of other studies which include smaller numbers of isolates which are usually not markedly resistant to aminoglycosides (3, 6, 9-11, 13, 14, 16) . The greatest activity for aminoglycosides in susceptible, intermediate, or resistant P. aeruginosa strains was observed with ceftazidime, imipenem, and cefsulodin. The MIC50s and MIC90s of cefoperazone, moxalactam, tnd cefmenoxime were similar, as was the MIC50 of aztreonam; but the MIC90 of aztreonam was severalfold higher. The most active penicillin was piperacillin, with MIC90 between 32 and 64 ,ug/ml, in contrast to ticarcillin, which had an MIC%0 that was threefold higher.
These data indicate that ceftazidime, imipenem, and cef- 
